OmegaTech Acquires Pharmacia's DHA Tech Rights
BOULDER, Colo.--OmegaTech Inc. reacquired the rights to production of DHA-rich marine algae. Pharmacia, formerly Monsanto, entered into the agreement with OmegaTech on June 13. As a result of the agreement, OmegaTech will be proceeding with its plans to develop a branded line of DHA GOLD ingredient products, designed for beverage and supplement applications.
"This agreement gives us the opportunity to drive the growth of DHA direct fortification in 11 nutritional product areas, including supplements, infant nutrition, active lifestyle foods and foods that support late adult life," said Mark Braman, OmegaTech's president and chief executive officer.
For more information, visit www.omegadha.com.